Correlation Between Duopharma Biotech and Magni Tech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Magni Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Magni Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Magni Tech Industries, you can compare the effects of market volatilities on Duopharma Biotech and Magni Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Magni Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Magni Tech.

Diversification Opportunities for Duopharma Biotech and Magni Tech

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Duopharma and Magni is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Magni Tech Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Magni Tech Industries and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Magni Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Magni Tech Industries has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Magni Tech go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Magni Tech

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to under-perform the Magni Tech. In addition to that, Duopharma Biotech is 1.15 times more volatile than Magni Tech Industries. It trades about -0.13 of its total potential returns per unit of risk. Magni Tech Industries is currently generating about 0.51 per unit of volatility. If you would invest  243.00  in Magni Tech Industries on September 1, 2024 and sell it today you would earn a total of  27.00  from holding Magni Tech Industries or generate 11.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Magni Tech Industries

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Magni Tech Industries 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Magni Tech Industries are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Magni Tech disclosed solid returns over the last few months and may actually be approaching a breakup point.

Duopharma Biotech and Magni Tech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Magni Tech

The main advantage of trading using opposite Duopharma Biotech and Magni Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Magni Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Magni Tech will offset losses from the drop in Magni Tech's long position.
The idea behind Duopharma Biotech Bhd and Magni Tech Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk